85 related articles for article (PubMed ID: 8108245)
21. Hepatic steatosis assessment with 1H-spectroscopy and chemical shift imaging at 3.0 T before hepatic surgery: reliable enough for making clinical decisions?
Koelblinger C; Krššák M; Maresch J; Wrba F; Kaczirek K; Gruenberger T; Tamandl D; Ba-Ssalamah A; Berger-Kulemann V; Weber M; Schima W
Eur J Radiol; 2012 Nov; 81(11):2990-5. PubMed ID: 22770582
[TBL] [Abstract][Full Text] [Related]
22. Liver fat and lipid oxidation in humans.
Kotronen A; Seppälä-Lindroos A; Vehkavaara S; Bergholm R; Frayn KN; Fielding BA; Yki-Järvinen H
Liver Int; 2009 Oct; 29(9):1439-46. PubMed ID: 19602132
[TBL] [Abstract][Full Text] [Related]
23. 1H NMR spectroscopic studies of lipid extracts from human fatty liver.
Pollesello P; Masutti F; Crocè LS; Toffanin R; Eriksson O; Paoletti S; Höckerstedt K; Tiribelli C
Biochem Biophys Res Commun; 1993 May; 192(3):1217-22. PubMed ID: 8507193
[TBL] [Abstract][Full Text] [Related]
24. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
Schuchmann S; Weigel C; Albrecht L; Kirsch M; Lemke A; Lorenz G; Warzok R; Hosten N
Eur J Radiol; 2007 Jun; 62(3):416-22. PubMed ID: 17267159
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.
Szczepaniak LS; Nurenberg P; Leonard D; Browning JD; Reingold JS; Grundy S; Hobbs HH; Dobbins RL
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E462-8. PubMed ID: 15339742
[TBL] [Abstract][Full Text] [Related]
26. Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy.
van Werven JR; Schreuder TC; Nederveen AJ; Lavini C; Jansen PL; Stoker J
Eur J Radiol; 2010 Aug; 75(2):e102-7. PubMed ID: 20116951
[TBL] [Abstract][Full Text] [Related]
27. In vivo 1H MR spectroscopy in the evaluation of the serial development of hepatocarcinogenesis in an experimental rat model.
Xu H; Li X; Yang ZH; Xie JX
Acad Radiol; 2006 Dec; 13(12):1532-7. PubMed ID: 17138121
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
29. Hepatocarcinogenesis tumor grading correlated with in vivo image-guided 1H-NMR spectroscopy in a rat model.
Towner RA; Foley LM; Painter DM
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):237-44. PubMed ID: 16023158
[TBL] [Abstract][Full Text] [Related]
30. Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat.
Lundbom J; Hakkarainen A; Söderlund S; Westerbacka J; Lundbom N; Taskinen MR
NMR Biomed; 2011 Apr; 24(3):238-45. PubMed ID: 20821410
[TBL] [Abstract][Full Text] [Related]
31. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
32. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
[TBL] [Abstract][Full Text] [Related]
33. [Reduced insulin effect in subclinical fatty liver].
Thamer C; Machann J; Haap M; Bachmann O; Wietek B; Dahl D; Tschritter O; Fritsche A; Jacob S; Schick F; Stumvoll M; Häring H
Dtsch Med Wochenschr; 2004 Apr; 129(16):872-5. PubMed ID: 15083407
[TBL] [Abstract][Full Text] [Related]
34. Proton chemical shift imaging: an evaluation of its clinical potential using an in vivo fatty liver model.
Rosen BR; Carter EA; Pykett IL; Buchbinder BR; Brady TJ
Radiology; 1985 Feb; 154(2):469-72. PubMed ID: 3966134
[TBL] [Abstract][Full Text] [Related]
35. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
[TBL] [Abstract][Full Text] [Related]
36. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
37. Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content.
van Werven JR; Hoogduin JM; Nederveen AJ; van Vliet AA; Wajs E; Vandenberk P; Stroes ES; Stoker J
J Magn Reson Imaging; 2009 Aug; 30(2):444-8. PubMed ID: 19629974
[TBL] [Abstract][Full Text] [Related]
38. Characterization of hepatic fatty acids in mice with reduced liver fat by ultra-short echo time (1)H-MRS at 14.1 T in vivo.
Soares AF; Lei H; Gruetter R
NMR Biomed; 2015 Aug; 28(8):1009-20. PubMed ID: 26119835
[TBL] [Abstract][Full Text] [Related]
39. [Proton magnetic resonance spectroscopy in the liver of HIV and HCV coinfected patients].
Wiercińska-Drapało A; Tarasów E; Lapiński TW
Przegl Epidemiol; 2005; 59(2):447-53. PubMed ID: 16190553
[TBL] [Abstract][Full Text] [Related]
40. [MRI and MRS in the diagnosis of cancer].
Itai Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):639-45. PubMed ID: 2539787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
